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Abstract
Background: Random-sequence peptide libraries are a commonly used tool to identify novel ligands for binding
antibodies, other proteins, and small molecules. It is often of interest to compare the selected peptide sequences
to the natural protein binding partners to infer the exact binding site or the importance of particular residues. The
ability to search a set of sequences for similarity to a set of peptides may sometimes enable the prediction of an
antibody epitope or a novel binding partner. We have developed a software application designed specifically for
this task.
Results: GuiTope provides a graphical user interface for aligning peptide sequences to protein sequences. All
alignment parameters are accessible to the user including the ability to specify the amino acid frequency in the
peptide library; these frequencies often differ significantly from those assumed by popular alignment programs. It
also includes a novel feature to align di-peptide inversions, which we have found improves the accuracy of
antibody epitope prediction from peptide microarray data and shows utility in analyzing phage display datasets.
Finally, GuiTope can randomly select peptides from a given library to estimate a null distribution of scores and
calculate statistical significance.
Conclusions: GuiTope provides a convenient method for comparing selected peptide sequences to protein
sequences, including flexible alignment parameters, novel alignment features, ability to search a database, and
statistical significance of results. The software is available as an executable (for PC) at http://www.immunosignature.
com/software and ongoing updates and source code will be available at sourceforge.net.
Background
Random-sequence peptide library screening approaches
represent an increasingly popular and powerful tool for
identifying binding partners for antibodies and other
proteins as well as carbohydrates, pharmaceuticals, and
other small molecules. Peptide library methods generally
fall into two categories: molecular display approaches
such as phage display, and immobilized arrays such as
SPOT. Display approaches can typically accommodate
much larger libraries, but information is typically
obtained only on the clones that survive several rounds
of panning, resulting in a population that is heavily
biased in favor of clones whose sequences facilitate
growth [1]. In contrast, array based approaches may be
used to screen smaller libraries with higher throughput
than display approaches and semi-quantitative binding
information is obtained on all of the peptides in the
library. New technologies both on the display side and
t h ea r r a ya p p r o a c hp r o m i s et oo v e r c o m et h e s el i m i t a -
tions [2-4]. The decreasing cost of both sequencing and
peptide synthesis as well as applications such as profil-
ing the humoral immune response [5] promise to
increase interest in connecting random-sequence pep-
tide mimotopes to protein sequences occurring in nat-
ure. Therefore, an increase in the demand for
appropriate algorithms and software to facilitate the
data analysis would also be expected.
While the peptides discovered in these library screen-
ing experiments serve as useful ligands in and of them-
selves, comparison of these sequences to natural protein
sequences can reveal novel biological insight. Peptides
selected by panning phage display libraries against
monoclonal antibodies often closely match the antibody
epitope making the sequence comparison rather
straightforward [6]. If a strong enough motif is
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used to search a database to predict an antibody target
[7]. Though current array technology does not allow
sufficient coverage of sequence space to contain
sequences closely resembling natural protein sequences
by chance, we have shown that experiments of this type
still have utility for predicting monoclonal epitopes [8].
Other groups have shown that peptides selected to bind
to other types of proteins have utility in understanding
and predicting binding to natural binding partners
[9-11]. Even small molecule binding peptides provide
insight on their binding to natural proteins [3,12].
Analysis of the peptide sequences obtained from any
selection experiment poses two key challenges. First, a
set of peptides need to be compared against a protein
database. Second, an appropriate scoring scheme is
needed to search for structural similarity rather than
evolutionary relationships. At first glance, the FASTS/
FASTF programs appear to address the first challenge,
as they are designed to take peptide sequences gener-
ated from protein sequencing techniques and identify
homologous proteins [13]. However, the FASTS/FASTF
programs search for cases where peptides align to non-
overlapping regions of the protein sequence, while we
would like to identify regions where the peptides align
to the same region of the protein sequence. Another
approach is to identify a motif among the selected pep-
tide sequences and use the consensus sequence or a
probabilistic representation of the motif to compare to
the protein sequence(s) of interest [14]. We previously
demonstrated that the glam2 motif finding program is
suitable for analyzing random-sequence peptide data
[8,15]. While the motif approach may be powerful in
many cases, the peptides of interest may not always
have a common pattern because different amino acids
may match in the same region of the sequence, or pep-
tides may align to different parts of the protein
sequence(s). Another approach would be to align each
discovered peptide sequence to the protein sequence
targets and sum the alignment scores at each position.
The RELIC MATCH program (not currently available
or supported) used this approach with some success
[3,9,10,12,16]. This program also had several limitations
with regards to transparency, flexibility, statistical analy-
sis, and the ability to search multiple sequences. Here
we present an open source application that gives the
user access to all parameters, can empirically estimate
the statistical significance of the results, and enables the
analysis of many sequences at once.
Methods
Algorithm overview
The user inputs protein sequence(s) to search, a set of
selected peptides, and (optionally) a representative or
complete list of peptides from the library. A scoring matrix
may be generated by the program as described below or
entered by the user. The maximal local alignment between
each selected peptide and protein sequence is found. If the
alignment score is greater than the user defined score
threshold, the score at each protein residue position is
added to the protein residue scores. If the moving average
window size is set to greater than one, after all peptides
have been aligned to a given protein, the moving average
across the protein residue positions is calculated and the
residue scores provided correspond to the score at the
start of the window. The same number of peptides as in
the selected list are randomly selected from the library if a
library set was entered, and these are aligned to the pro-
tein(s) in the same manner as for the selected peptides;
this process is repeated for the specified number of sam-
pling iterations. If the subtract library scores box is
checked, the average scores at each residue position from
the randomly selected peptides from the library are sub-
tracted from the residue scores. The selected peptide
scores across each protein sequence are graphed, as well
as the maximum and average scores from the random
sampling iterations. The user may use the sort button to
order the proteins by their maximal residue scores. The
text output tab may be used to view a summary table of
the maximum alignment scores for each protein or a table
of all of the alignments identified for the number of pro-
teins specified.
Scoring matrix
GuiTope generates a log-odds-like scoring matrix based
on a given measure of amino acid distances and amino
acid frequencies. The distance matrix is taken to be
inversely proportional to the frequencies of an amino
acid pair appearing in a true alignment after a pseudo-
count of 10% of the average distance is added to the dis-
tance matrix to avoid dividing by zero. The rows and
columns are iteratively scaled to sum to the expected
amino acid frequencies. This matrix is then divided by
the product of protein and peptide amino acid frequen-
cies at each position and log10 transformed.
Alignment algorithm and inversion scoring
The maximal gapless local alignment of each peptide
with each protein is calculated using the Smith-Water-
man algorithm. If the inversion weight is set to greater
than 0, the program will identify sequence positions
where the protein residue at position i is the same as
the peptide residue at position j +1 AND the protein
residue at position i+1 is the same as the peptide resi-
due at position j. The residue scores for these inversions
will be the product of the inversion weight and the aver-
age of the identity scores for the amino acids at the pro-
tein positions i and i+1.
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For each sampling iteration and each protein sequence,
a set of peptides, with the same number of peptides as
the selected peptide list, is randomly selected from the
library and the residue scores are calculated. From
these, the maximum and average residue scores are cal-
culated for each position. If the ‘subtract library scores’
option is selected, the average library scores are sub-
tracted from the residue scores from each iteration. The
maximum scores from each protein iteration are ranked.
For each protein, the maximum residue score from the
selected peptides is compared to the ranked scores. The
percentage of library scores that are higher than the
selected peptide score is reported as the significance.
Evaluation datasets
A dataset was previously described containing lists of
peptide sequences identified from random-sequence
peptide microarray experiments as binding to monoclo-
nal antibodies with known epitopes [8]. This dataset was
used to optimize Guitope’s alignment parameters. A
polyclonal anti-peptide dataset from the same publica-
tion was used to evaluate the algorithm. Additionally,
another set of monoclonal antibodies with known epi-
topes was used to probe a completely different set of
10,000 random-sequence peptides on a microarray. The
two anti-P53 antibodies from the first monoclonal anti-
body dataset were repeated on both the first and second
version of the 10,000 peptide microarrays. Additionally,
an anti-cMyc clone 9E10 (AbD SeroTec, Raleigh), anti-
Leu-Enkaphalin clone 1193/220 (AbD SeroTec, Raleigh),
anti-PBEF clone E10 (Santa Cruz Biotechnology), and
anti-V5 (AbD SeroTec, Raleigh) were used to probe the
array and generate lists of peptides to which the antibo-
dies bound. Anti-cMyc, anti-Leu-Enkaphalin, and anti-
V5 recognize epitope tags, while the anti-PBEF was epi-
tope mapped using tiling peptides (current authors,
manuscript in preparation). Phage display datasets that
identified the greatest number of unique peptides were
selected from those listed in the “several binding sites”
category in Derda et al. [1] and these were downloaded
from MimoDB http://immunet.cn/mimodb/. These
phage display datasets include peptides selected against
a diverse set of targets, including two human extracellu-
lar proteins, one bacterial protein, and immune sera to a
virus and a bacterium.
Implementation
GuiTope was implemented in Visual Basic, using the
M i c r o s o f t. N E Tf r a m e w o r k .I tm a yb ei n s t a l l e do na n y
computer running Microsoft Windows XP or a newer
Windows operating system. It has a memory footprint
of 400 MB and will take anywhere between seconds to
several minutes to run a set of hundreds of peptides
against a single protein with 100 sampling iterations on
a single Pentium 4 core, 3.2 GHz and 2 GB RAM
machine running Windows XP. On the same hardware,
searching a protein database of ~20,000 proteins with a
set of several hundred peptides with a single sampling
iteration, will utilize < 3 GB of memory and use
approximately 20 hours of direct CPU time.
Results and discussion
The optimal combination of parameters for GuiTope
was determined by testing on a previously described
dataset of peptide sequences bound by monoclonal anti-
bodies with known epitopes that had been used to
probe a random-sequence peptide array. [8] Epitope
predictions were evaluated using ROC analysis and the
AUROC scores are reported in Figure 1. The most criti-
cal parameter appears to be the scoring matrix, with the
BLOSUM62 matrix having an AUROC 0.15 less than
the GuiTope method which adjusts for altered amino
acid frequencies. The di-peptide inversion method also
had a substantial improvement in the AUROC score.
The di-peptide inversion method is a novel alignment
approach that we developed after observing such align-
ments in our data. We hypothesize that the flexibility of
the peptides enables the inverted amino acids to have
similar interactions with the paratope and we have
found some preliminary experimental and modeling evi-
dence supporting the di-peptide inversion (data not
shown). Here we have included results from analysis
with and without di-peptide inversions since the
approach is unusual. The library subtraction method
only yields a small improvement to the score and a
large number sampling iterations are required to accu-
rately estimate the average library score, so we only
Figure 1 Parameter Optimization. The AUROC (Area Under the
Receiver Operator Characteristics Curve) is shown for each
parameter value tested on the 1
st Known Epitope Monoclonal
Dataset shown below. The best parameter value was highlighted
and that value was used when each other value was varied.
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teins rather than for database searches in order to keep
run times reasonable.
GuiTope was tested on two independent datasets
obtained by probing random-sequence peptide microar-
rays with antibodies. The first was obtained by probing
an array of 10,000 random-sequence peptides, having
completely different sequences than those used in the
training set, with monoclonal antibodies having known
linear epitopes. The monoclonal epitopes were predicted
with an AUROC score of 0.75 using the inversion
method and 0.78 without inversions (Figure 2A). It
appears that this dataset is more difficult to predict as
the RELIC and glam2 methods also perform worse. The
second peptide microarray evaluation dataset was gener-
ated from polyclonal anti-peptide sera. Here GuiTope
performs similarly to previously tested methods with an
A U R O Co f0 . 6 8u s i n gt h ei n v e r s i o nm e t h o da n d0 . 5 6
without inversions, compared to an AUROC of 0.48
using RELIC method and 0.68 using Glam2 (Figure 2B).
These microarray datasets are likely considerably more
difficult than phage display datasets because of sparse
sampling of sequence space.
Phage display datasets evaluated in GuiTope were
selected based on the summary of the MimoDB pub-
lished in Derda et al. [1]. Two of these datasets con-
sisted of peptides selected to polyclonal sera. The phage
display peptides selected against the anti-Nipah virus
were used to map three epitopes on the nucleoprotein,
and GuiTope also identified these epitope regions (Fig-
ure 3A). GuiTope also predicted an epitope on Glyco-
protein G that was also predicted by DiscoTope [17],
which uses the crystal structure to identify accessible
regions (Figure 3B). Yang et al. identified some regions
of sequence similarity between the anti-Mycoplasma
hyopneumoniae selected peptides and several M. hyop-
neumoniae protein sequences, but did not test whether
their epitope predictions were correct [18]. The only
experimentally determined Mycoplasma hyopneumoniae
B-cell epitopes in the Immune Epitope Database [19]
were determined by a peptide tiling study of predicted
lipoproteins [20]. None of these epitopes were predicted
by the Yang et al. or the GuiTope analysis. Most likely
the phage display selected peptides correspond to epi-
topes on proteins other than the lipoproteins. There is
no structural or experimental data to evaluate GuiTope’s
predictions of the Mycoplasma hyopneumoniae epitopes.
Three protein panning datasets were also evaluated. In
the first example, White et al. did not identify any simi-
larity between the peptides found to bind to the
endothelial protein C receptor (EPCR) and Protein C or
any other known EPCR binding partners. GuiTope like-
wise did not find any significant similarity between any
known EPCR interactors (Figure 4C). In the second
case, the peptides selected to bind to integrin a5b6 were
mapped by GuiTope to the known interactors TGF beta
1 and TGF beta 3 as two of the top three hits (Table 1)
and Guitope correctly identified the important interact-
ing amino acids (Figure 4B). Since these interactions
were discovered after the publication of the phage dis-
play study, one may suppose that they could have been
predicted from the phage display data if the proper
Figure 2 Peptide Microarray Evaluation Datasets.P e p t i d e s
selected to bind known epitope monoclonals (A) or anti-peptide
polyclonal sera (B) were used to predict the epitope (A) or
immunizing peptide (B) in GuiTope, RELIC, or Glam2 within a
database of decoy sequences. The significance scores of the true
epitope or immunizing peptide sequences was compared to the
decoy sequences using ROC plots, where the true positive rate is
plotted against the false positive rate for all possible score
thresholds. The results using the inversion weight as one are
plotted in blue, the results without inversions are plotted in red, the
results for RELIC are plotted in green, and the results for Glam2 are
plotted in black. The AUROC value shown in the legend indicates
the probability that a true sequence would score higher than a
decoy sequence for that dataset. *Note that the RELIC analysis of
the monoclonal set is only based on five monoclonal antibodies
because the sixth antibody was run after the server was no longer
available.
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Page 4 of 7Figure 3 Analysis of Anti-Nipah Dataset. A. Screen shot of GuiTope mapping of anti-Nipah Virus selected peptides to the Nipah
Nucleoprotein. Epitopes previously predicted and validated from this phage display peptide set are indicated with arrows. B. Novel GuiTope
predictions using the inversion method of Nipah Glycoprotein G epitopes. The GuiTope alignment detail is shown as well as the locations of
these epitopes in the crystal structure. The underlined glutamic acid is part of the receptor binding site.
Figure 4 Protein Interaction Predictions. A. Peptides selected to bind Integrin AlphaV Beta6 clearly aligned in GuiTope to the integrin binding
site on TGF beta 1. B. Detailed alignments of the peptides to TGF beta 1, with those that align to the binding site highlighted in yellow and
those that do not contain the RGB motif shown in italic. Below the WebLogo view of peptides aligning to the region illustrates the relative
importance of amino acids C. Peptides selected to bind to EPCR do not align to a particular region on protein C.
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Carettoni et al. nor the Guitope analysis reveal a clear
similarity between the FtsA binding peptides and a
known FtsA interactor. Carettoni et al. identified a weak
motif that matched a site on FtsA, and used that site to
develop a model for the structure of the FtsA dimer
[21]. While several lines of evidence suggest that E. Coli
FtsA does form a dimer, it is not clear whether the
model proposed based on this phage-display data is cor-
rect [22]. We are not aware of any experimental evi-
dence to support or refute the interactions predicted by
GuiTope.
The peptides that bind to a given target do not always
have sequences that are similar to biologically relevant
proteins. This problem is confounded when peptide array
approaches are used because peptides that are highly
similar to a given protein are unlikely to be present in the
library. GuiTope was able to take these loosely similar
sequences and predict antibody epitopes with modest
accuracy (AUROC 0.75-0.9) in line with previously tested
methods [8]. Random-sequence peptide microarrays have
shown great promise in profiling the humoral immune
response [5,23], and it would be of great utility to be able
to use the peptide sequences to trace back to the antigen
that elicited the immune response. However, the current
prediction accuracy would not be sufficient for this task
[8]. In contrast to the peptide array datasets, the phage
display selected peptides can sometimes be used to pre-
dict interaction partners from a database very accurately.
As less biased molecular display methods are developed
and higher density peptide arrays become available, we
expect that the information content of the peptide
sequences will improve, making the type of analysis facili-
tated by GuiTope even more useful.
Availability and requirements
The executable is available on http://www.immunosigna-
ture.com/software and will install and run on any PC
with Windows XP or later. The source code is written
in Visual Basic and available on sourceforge.net. The
Microsoft .NET framework is required.
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